Breaking Down Barriers - Following Up with Wave Life Sciences

Over a year ago, we broke down the SELECT-HD trial by Wave Life Sciences looking at an allele-selective approach to Huntingtin Lowering. They just released their data on the trial this summer, and we sat down with them again to look at that data and understand future plans. Join us to learn more!
Multiple languages are available through closed captioning.
Take a look at the other conversation in our Breaking Down Barriers KZbin Playlist.
Breaking Down Barriers is sponsored by Roche, Sage Therapeutics, Teva Pharmaceutical, uniQure, Wave Life Sciences, Neurocrine Biosciences, PTC Therapeutics and the Griffin Foundation.

[@Jaeearth]

❤